I specialized in hematopoietic cell transplantation and cellular therapy, with a particular expertise in providing care for patients with lymphoma, as well as in cardio-oncology. My research has been dedicated to improving long-term outcomes for all patients, with a special emphasis on those who are frail or have refractory disease. I am committed to enhancing patients' quality of life by mitigating the harmful effects of therapy-induced toxicities.